Saquinavir exposure in HIV-infected patients with chronic viral hepatitis | Zendy

José Moltó | Zendy; Josep M. Llibre | Zendy; Esteban Ribera | Zendy; Carlos Mínguez | Zendy; J. Sánchez del Río | Zendy; Enric Pedrol | Zendy; Gabriel Vallecillo | Zendy; Samandhy Cedeño | Zendy; Marta Valle | Zendy; C Miranda | Zendy; Eugènia Negredo | Zendy; B. Clotet | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis

Author(s) -

José Moltó,

Josep M. Llibre,

Esteban Ribera,

Carlos Mínguez,

J. Sánchez del Río,

Enric Pedrol,

Gabriel Vallecillo,

Samandhy Cedeño,

Marta Valle,

C Miranda,

Eugènia Negredo,

B. Clotet

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp070

Subject(s) - saquinavir , ritonavir , medicine , gastroenterology , pharmacology , pharmacokinetics , virology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy

The aim of this study was to assess the influence of hepatitis B virus or hepatitis C virus co-infection and the extent of liver fibrosis on saquinavir and ritonavir pharmacokinetics in HIV-infected subjects without liver function impairment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research